- Prescribing Advice for GPs - https://www.prescriber.org.uk -

Saxagliptin safety information

The manufacturer has written to healthcare professionals regarding new safety information for saxagliptin (Onglyza®).

The letter advises that saxagliptin has been associated with serious hypersensitivity reactions and acute pancreatitis. The following recommendations have now been made:

Action: Clinicians should be aware of this new safety information and implement any necessary changes to practice.